دورية أكاديمية
أعرض في EDS

Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure.

التفاصيل البيبلوغرافية
العنوان: Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure.
المؤلفون: Pagnesi M; Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia., Riccardi M; Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia., Chiarito M; Humanitas Research Hospital IRCCS, Rozzano-Milan.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan., Stolfo D; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste., Baldetti L; Cardiac Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Lombardi CM; Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia., Colombo G; Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia., Inciardi RM; Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia., Tomasoni D; Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia., Loiacono F; Humanitas Research Hospital IRCCS, Rozzano-Milan., Maccallini M; Humanitas Research Hospital IRCCS, Rozzano-Milan.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan., Villaschi A; Humanitas Research Hospital IRCCS, Rozzano-Milan.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan., Gasparini G; Humanitas Research Hospital IRCCS, Rozzano-Milan.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan., Montella M; Humanitas Research Hospital IRCCS, Rozzano-Milan.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele-Milan., Contessi S; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste., Cocianni D; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste., Perotto M; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste., Barone G; Cardiac Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Merlo M; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste., Cappelletti AM; Cardiac Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Sinagra G; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste., Pini D; Humanitas Research Hospital IRCCS, Rozzano-Milan., Metra M; Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia., Adamo M; Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological sciences and Public Health, University of Brescia, Brescia.
المصدر: Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2024 Mar 01; Vol. 25 (3), pp. 200-209. Date of Electronic Publication: 2024 Jan 09.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101259752 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-2035 (Electronic) Linking ISSN: 15582027 NLM ISO Abbreviation: J Cardiovasc Med (Hagerstown) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins, c2006-
مواضيع طبية MeSH: Heart Failure* , Mitral Valve Insufficiency* , Tricuspid Valve Insufficiency*/diagnostic imaging, Humans ; Retrospective Studies ; Stroke Volume ; Treatment Outcome ; Tricuspid Valve/diagnostic imaging ; Tricuspid Valve/surgery ; Ventricular Function, Left ; Multicenter Studies as Topic ; Observational Studies as Topic
مستخلص: Aims: To evaluate the role of tricuspid regurgitation in advanced heart failure.
Methods: The multicenter observational HELP-HF registry enrolled consecutive patients with heart failure and at least one 'I NEED HELP' criterion evaluated at four Italian centers between January 2020 and November 2021. Patients with no data on tricuspid regurgitation and/or receiving tricuspid valve intervention during follow-up were excluded. The population was stratified by no/mild tricuspid regurgitation vs. moderate tricuspid regurgitation vs. severe tricuspid regurgitation. Variables independently associated with tricuspid regurgitation, as well as the association between tricuspid regurgitation and clinical outcomes were investigated. The primary outcome was all-cause mortality.
Results: Among the 1085 patients included in this study, 508 (46.8%) had no/mild tricuspid regurgitation, 373 (34.4%) had moderate tricuspid regurgitation and 204 (18.8%) had severe tricuspid regurgitation. History of atrial fibrillation, any prior valve surgery, high dose of furosemide, preserved left ventricular ejection fraction, moderate/severe mitral regurgitation and pulmonary hypertension were found to be independently associated with an increased likelihood of severe tricuspid regurgitation. Estimated rates of 1-year all-cause death were of 21.4, 24.5 and 37.1% in no/mild tricuspid regurgitation, moderate tricuspid regurgitation and severe tricuspid regurgitation, respectively (log-rank P  < 0.001). As compared with nonsevere tricuspid regurgitation, severe tricuspid regurgitation was independently associated with a higher risk of all-cause mortality (adjusted hazard ratio 1.38, 95% confidence interval 1.01-1.88, P  = 0.042), whereas moderate tricuspid regurgitation did not.
Conclusion: In a contemporary, real-world cohort of patients with advanced heart failure, several clinical and echocardiographic characteristics are associated with an increased likelihood of severe tricuspid regurgitation. Patients with severe tricuspid regurgitation have an increased risk of mortality.
(Copyright © 2024 Italian Federation of Cardiology - I.F.C. All rights reserved.)
References: Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging 2019; 12:433–442.
Bartko PE, Hülsmann M, Hung J, et al. Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction. Eur Heart J 2020; 41:2799–2810.
Benfari G, Antoine C, Miller WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation 2019; 140:196–206.
Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 2017; 19:1574–1585.
Bartko PE, Arfsten H, Frey MK, et al. Natural history of functional tricuspid regurgitation. JACC Cardiovasc Imaging 2019; 12:389–397.
Topilsky Y, Inojosa JM, Benfari G, et al. Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction. Eur Heart J 2018; 39:3584–3592.
Messika-Zeitoun D, Verta P, Gregson J, et al. Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis. Eur J Heart Fail 2020; 22:1803–1813.
Neuhold S, Huelsmann M, Pernicka E, et al. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J 2013; 34:844–852.
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43:561–632.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143:e72–e227.
Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol 2017; 70:2953–2960.
Kilic A, Saha-Chaudhuri P, Rankin JS, Conte JV. Trends and outcomes of tricuspid valve surgery in North America: an analysis of more than 50,000 patients from the Society of Thoracic Surgeons Database. Ann Thorac Surg 2013; 96:1546–1552.
Dreyfus J, Audureau E, Bohbot Y, et al. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J 2022; 43:654–662.
Mangieri A, Pagnesi M, Regazzoli D, et al. Future perspectives in percutaneous treatment of tricuspid regurgitation. Front Cardiovasc Med 2020; 7:581211.
Sorajja P, Whisenant B, Hamid N, et al. TRILUMINATE Pivotal Investigators. Transcatheter repair for patients with tricuspid regurgitation. New Engl J Med 2023; 388:1833–1842.
Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol 2019; 74:2998–3008.
Pagnesi M, Lombardi CM, Chiarito M, et al. Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry. Eur J Heart Fail 2022; 24:1493–1503.
Villaschi A, Pagnesi M, Stolfo D, et al. Ischemic etiology in advanced heart failure: insight from the HELP-HF Registry. Am J Cardiol 2023; 204:268–275.
Pagnesi M, Ghiraldin D, Vizzardi E, et al. Detailed assessment of the ‘I Need Help’ criteria in patients with heart failure: insights from the HELP-HF Registry. Circ Heart Fail 2023; e011003.
Pagnesi M, Lombardi CM, Tedino C, et al. Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry. ESC Heart Fail 2023; doi: 10.1002/ehf2.14539. [article-in-press]. (PMID: 10.1002/ehf2.14539.)
Mutlak D, Lessick J, Khalil S, Yalonetsky S, Agmon Y, Aronson D. Tricuspid regurgitation in acute heart failure: is there any incremental risk? Eur Heart J Cardiovasc Imaging 2018; 19:993–1001.
Cocianni D, Stolfo D, Perotto M, et al. Association of tricuspid regurgitation with outcome in acute heart failure. Circ Cardiovasc Imaging 2023; 16:566–576.
Hahn RT. Tricuspid regurgitation. New Engl J Med 2023; 388:1876–1891.
Patlolla SH, Schaff HV, Nishimura RA, et al. Incidence and burden of tricuspid regurgitation in patients with atrial fibrillation. J Am Coll Cardiol 2022; 80:2289–2298.
Heitzinger G, Pavo N, Koschatko S, et al. Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum. Eur J Heart Fail 2023; 25:857–867.
Adamo M, Chioncel O, Benson L, et al. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: an analysis from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail 2023; 25:1061–1071.
Lancellotti P, Magne J. Tricuspid valve regurgitation in patients with heart failure: does it matter? Eur Heart J 2013; 34:799–801.
Palmieri V, Amarelli C, Mattucci I, et al. Predicting major events in ambulatory patients with advanced heart failure awaiting heart transplantation: a pilot study. J Cardiovasc Med (Hagerstown) 2022; 23:387–393.
Bonelli A, Pagnesi M, Inciardi RM, et al. Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure. J Cardiovasc Med (Hagerstown) 2023; 24:564–574.
تواريخ الأحداث: Date Created: 20240122 Date Completed: 20240215 Latest Revision: 20240215
رمز التحديث: 20240216
DOI: 10.2459/JCM.0000000000001582
PMID: 38251453
قاعدة البيانات: MEDLINE
الوصف
تدمد:1558-2035
DOI:10.2459/JCM.0000000000001582